新华制药上年度净现金流为3.55亿元同比增长255.05%

金融界
30 Mar

新华制药年报数据显示,2024年1-12月,公司净现金流为3.55亿元同比增长255.05%,其中,经营性现金流3.68亿元,投资性现金流-2.12亿元,融资性现金流1.85亿元。报告期内,公司销售商品、提供劳务收到的现金为79.41亿元,取得投资收益收到的现金为818.22万元,购建固定资产、无形资产和其他长期资产支付的现金为2.12亿元。资料显示,山东新华制药股份有限公司成立于1998年,位于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10